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Mannans are highly water-soluble mannose heteropolymers produced by a number of organisms, 
including yeasts. Polyhydroxyalkanoates (PHAs) are aliphatic polyesters produced by numerous 
bacteria as a carbon and energy source, with interesting thermal and mechanical properties. 
The main objective of this thesis was to prepare different polymeric structures base on mannans and 
PHAs for use in the pharmaceutical and biomedical areas. Mannans were produced by Komagataella 
pastoris using glycerol as carbon source, extracted with a heat-alkali treatment and purified using 
dialysis. PHAs were produced by mixed cultures using fermented fruit pulp waste, extracted using 
chloroform or hypochlorite and purified in ethanol. 
A successful deproteinization and an unsuccessful phosphorylation procedure was performed in 
mannans. The results show a decrease in protein content of 69.49 ± 0.44 % and a decrease in 
phosphate content of 60.45 ± 1.23 %, respectively. 
Mannans were tested in normal fibroblasts, HCT116 and A2780 cell lines for their cytotoxicity, by MTS 
assay, and no cytotoxicity was discovered. They were then used to prepare gel structures, and gelled 
using di- and tri-valent cations of iron and copper at low temperature (4 ⁰C) and alkaline pH. Gel 
particles were obtained in the above conditions and tested for their stability in water. Particles made 
using tri-valent iron were found the most stable. 
Mannans were also used to produce films. Films were obtained from i) mannans in water dried at 30 
⁰C or freeze dried, ii) from the previously produced films (30 ⁰C) and then coated with iron, at neutral 
pH or followed by immersion in an alkaline solution and, iii) from gel beads dried at 30 ⁰C or freeze 
dried. Films were tested for cell adhesion in vitro using normal fibroblasts, but no positive results were 
found. 
PHAs with different HV ratios were used to produce films, pure and blended with mannans, using 
chloroform as solvent by a solvent casting method. The produced films were tested for cell adhesion in 
vitro, using fibroblasts and MCF7-GFP. Pure PHA films were deemed good matrices for this 
application with cells adherent to their surface, whereas blend matrices failed in this regard. Some 
pure PHA matrices were then tested for their cytotoxicity using MCF7-GFP, and with the exception of 
co-polymer PHBHV with HV content of 18 % (extracted with hypochlorite), they were found to be non-
cytotoxic, rendering them useful for biomedical applications such as wound dressing or drug delivery. 
 
 
Keywords: Mannans; Polyhydroxyalkanoates; Mannans gel beads; Polymeric Films; Cytotoxicity 
assays; Cell adherence assays. 
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Mananos são heteropolímeros de manose altamente solúveis em água produzidos por vários 
organismos, incluindo leveduras. Polihidroxialcanoatos (PHAs) são poliésteres alifáticos produzidos 
por diversas bactérias como fonte de carbono e energia, com interessantes propriedades térmicas e 
mecânicas. 
O principal objetivo desta tese foi preparar diferentes estruturas poliméricas baseadas em mananos e 
PHAs para uso nas áreas farmacêutica e biomédica. Os mananos foram produzidos por 
Komagataella pastoris usando glicerol como fonte de carbono, extraídos com um tratamento térmico 
e alcalino, e purificados por diálise. Os PHA foram produzidos por culturas mistas utilizando resíduos 
de polpa de fruta fermentada, extraídos usando clorofórmio ou hipoclorito e purificados em etanol. 
Foi realizada em mananos uma desproteinização com sucesso e um procedimento de fosforilação 
sem sucesso. Os resultados mostram uma diminuição no conteúdo em proteína de 69,49 ± 0,44 % e 
uma diminuição no conteúdo em fosfato de 60,45 ± 1,23 %, respectivamente. 
Os mananos foram testados em fibroblastos normais e nas linhas celulares HCT116 e A2780 para 
avaliar a sua citotoxicidade, através de um ensaio MTS, e não foi descoberta nenhuma citotoxicidade. 
Estes foram então usados para preparar estruturas de gel, e gelificaram usando catiões di- e 
trivalentes de ferro e cobre a baixa temperatura (4 ⁰C) e pH alcalino. As partículas de gel foram 
obtidas nas condições acima e testadas quanto à sua estabilidade em água. As partículas feitas com 
ferro trivalente foram consideradas as mais estáveis. 
Este polímero foi ainda utilizado para produzir filmes. Os filmes foram obtidos de i) mananos em 
água, secos a 30 ⁰C ou liofilizados, ii) filmes produzidos anteriormente (30 ⁰C) e revestidos com ferro, 
a pH neutro ou seguidos de imersão em solução alcalina e, iii) esferas de gel secas a 30 ⁰C ou 
liofilizadas. Estes filmes foram testados quanto à adesão celular in vitro utilizando fibroblastos 
normais, mas não foram encontrados resultados positivos. 
Foram utilizados PHAs com diferentes rácios de HV para produzir filmes, puros e misturados com 
mananos, utilizando clorofórmio como solvente. Os filmes produzidos foram testados quanto à 
adesão celular in vitro, utilizando fibroblastos e MCF7-GFP. Os filmes de PHA puro foram 
considerados boas matrizes para esta aplicação, com células aderentes à sua superfície, enquanto 
que nas matrizes de mistura se verificou pouca adesão celular. Algumas matrizes de PHA puro foram 
então testadas quanto à sua citotoxicidade usando MCF7-GFP e, com exceção do co-polímero 
PHBHV com teor de HV de 18 % (extraído com hipoclorito), verificou-se não serem citotóxicas, 
tornando-se úteis para aplicações biomédicas tais como revestimento de feridas e libertação 
controlada de fármacos. 
 
 
Palavras-chave: Mananos; Polihidroxialcanoatos; Partículas de gel de mananos; Filmes poliméricos; 
Ensaios de viabilidade celular; Ensaios de adesão celular. 
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Many polymers of both natural and synthetic origin have been proposed and used in a variety of 
applications, including biomedical applications [1]. Natural polymers present an array of interesting 
properties suitable for diverse applications, which investigators have tried to replicate in the course of 
producing synthetic polymers. The natural counterparts, however, have been refined for billions of 
years, and are therefore still ahead [2]. 
Natural polymers are called so regarding their biotic origin, commonly being produced in animals or 
plants, but also in microorganisms. In fact, the interest in microbial products has been, and still is, 
increasing [3]. 
Regarding these biopolymers, three different macrostructures arise, comprising polysaccharides, 
polyesters and proteins [1, 4]. While undoubtfully important, the latter category falls out of interest to 
the purpose of this thesis, and will therefore be disregarded. 
 
 
Polysaccharides can either be homopolymers or heteropolymers, respective to their chemical 
composition. Homopolymers (homopolysaccharides) are constituted by a single repeating monomer, 
the most common example being glucose homopolysaccharides (such as cellulose) [5]. 
Heteropolymers (heteropolysaccharides) are constituted by multiple different monomers, in various 
proportions. Glucose, galactose or rhamnose are among the most common monomers, but other 
monomers are also often found, such as mannose, N-acetylglucosamine or non-carbohydrate 
substituents, such as phosphate or glycerate [5]. 
Many naturally occurring polysaccharides from various origins (plant, algae, crustacean, fungal and 
bacterial) have been extensively studied and are currently being used in commercial products in 
different areas (food, pharmaceutical, cosmetic industry, among others), replacing synthetic polymers, 
as these natural polymers are more biodegradable, biocompatible and non-toxic. Some examples 
include Arabic gum (plant), carrageenan (algae), cellulose (plant, microbial), xanthan gum or gellan 
gum (microbial) [6]. 
Some of these natural sources of polysaccharides (plants, algae and crustacean), however, present 
meaningful drawbacks in terms of production and polymer extraction, either caused by seasonal 
constraints (long-term, unreliable productions, both regarding quantity and quality) or expensive 
purification methods to remove toxic or allergenic natural components, which may otherwise render 
the polymers inadequate for human use. Microbial polysaccharide production, on the other hand, can 
be more easily controlled and manipulated. Modern bioengineering techniques can achieve 
reproducible and high yielding polymer productions, in faster growth and production periods, while 
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sometimes couple those advantages with the use of cheap carbon sources obtained from industrial 
wastes and by-products [7]. 
Moreover, biopolymers obtained from microbial sources may comprise a series of inherent mechanical 
properties (such as gelling capacity, emulsifier, thickener, pH and thermal stability or film forming 
capacity), as well as functional properties (immune response increase, antimicrobial activity, 
antimutagenic activity, antitumor activity, among others), and can even be modulated (for example, 
novel chemical groups or metal addition for specific properties) to achieve intensified or novel 
properties [3, 8–10]. 
 
 
Yeast polysaccharides have been studied over the last few years, and the many properties 
ascertained so far have led to their proposal for healthcare related purposes, namely in 
pharmaceutical and biomedical applications, despite their clinical use still not being widespread [3]. 
These polymers can be categorized in mainly three types of polymers: cell-wall polysaccharides, 
capsular and extracellular polysaccharides. Extracellular polysaccharides are synthesized inside the 
yeast cell, and then transported to the extracellular environment. They can remain free in the medium 
(EPS) to form an involving matrix to support and protect the culture, as well as provide a means to 
interact with a possible host, or remain attached to the fungi cell wall (capsular polysaccharides) to 
confer an extra layer of protection [3]. 
Cell-wall polysaccharides are almost ubiquitous among yeast, composed of an outer layer of mannans 
and mannoproteins and an inner layer of D-glucans, chitin and chitosan and their respective 
complexes with glucans, chitin-glucan complexes (CGC), and chitosan-glucan complexes (ChGC) [3]. 
The cell-wall polysaccharides have various purposes. The inner layer is mostly responsible for 
structural support of the yeast cell, accounting for its stability [11]. CGC connects to a network of 
different glucans, providing some flexibility to the cell wall, as well as functioning as structural 
elements connecting the rigid CGC shell to the outer mannans and mannoproteins layer [12]. 
 
 
The outer layer of the yeast cell wall is composed of mannans and mannoproteins and is an 
amorphous matrix of mannose heteropolymers. In yeast cells, these polysaccharides and 
glycoproteins have many functions, such as controlling the cell wall permeability or interacting with the 
medium. In some pathogenic strains, such as Candida albicans, they are used by the yeast to adhere 
to surfaces [13]. 
Mannose backbone chains, which may also contain other sugars, such as glucose or galactose (called 
 3 
 
glucomannans or galactomannans, respectively), are linked by α-1,3-, α-1,6-, β-1,3- and β-1,4- 
glyosidic links. Mannans backbones are often highly branched, presenting an even vaster array of 
sugar side chains and their substituents, such as glucose and galactose, but also fucose, xylose, 
mannose and glucuronic acids, as well as non-carbohydrate versions of the previous (such as 
phosphorylated versions), to name a few. Some yeast mannans have been reported to have mannose 
contents over 90 % [3]. 
Mannoproteins are glycoproteins constituted by a central protein linked to two side chains of 
heteropolymer mannan, a long chain (usually up to 100 monomers) which is highly branched, and a 
smaller chain with usually no more than 5 monomers, which are linked to the central protein through 
asparagine and threonine or serine residues, respectively. Mannans and mannoproteins are produced 
in the endoplasmic reticulum from a nucleotide diphosphate mannose, GDP-Man. Mannosyl residues 
are obtained from GDP-Man by mannosyltransferases, which are then linked together in a linear form 
and bound to the proteins. The glycoproteins are then conducted to the cell wall by proper vesicles [3]. 
A scheme comprising the formation of yeast cell wall components is presented on figure 1.1. 
 
 
Figure 1.1. Simplified scheme for the formation of yeast cell wall components.  
Adapted from Freitas et al. [3]. 
 
Many different kinds of mannans are naturally produced, with different biological activity properties, 
including immunomodulator, antimicrobial, antiviral, antioxidant or antimutagenic activity. Remarkably 
so, phosphomannans (mannans with a high presence of diester phosphate linked side chains) have 
been proved to possess antitumoral effect, especially when chemically modified to include other 
substituents such as sulphates [14, 15]. 
 4 
 
 
Polyesters are polymers whose repetitive units are bound together by ester linkages [16, 17]. They are 
usually obtained by esterification of dicarboxylic acids and dihydroxyl alcohols, and esterification can 
occur on either end of the molecules, allowing for vast polymeric chains to be produced [18]. 
Trihydroxyl alcohols and tricarboxylic acids can also be used, with esterification occurring in multiple 
sites, in which case the resulting polymer has a chance to contain crosslinks in its structure [18]. 
Polyesters can be divided into aliphatic and aromatic. Aromatic polyesters are polyesters which 
contain aromatic residues in their structure, whether part of the original monomers or co-polymerized 
with it [19]. These aromatic residues are responsible for the polymers lack of biodegradability, as most 
enzymes’ active center cannot fit the cyclic carbon structure of the aromatic and therefore degrade the 
polymer [20]. The most notorious example of aromatic polyesters is polyethylene terephthalate (PET), 
commonly used in the food industry to produce plastic PET bottles [18]. 
Aliphatic polyesters are usually regarded as polymers with high biocompatibility and 
biodegradability/bioresorbability, and have therefore been proposed in numerous applications in the 
medical field, such as sutures, drug delivery vehicles, tissue engineering or implants [21, 22], as well 
as in food and agriculture fields as packaging materials. These polymers include polylactic acid (PLA) 
and poly(ε-caprolactone) (PCL) which are commercially available, but also other polymers with 
interesting properties such as polyhydroxyalkanoates (PHAs) [16]. 
 
 
Polyhydroxyalkanoates (PHAs) are naturally occurring aliphatic polyesters produced by some 
organisms, including bacteria, as a carbon and energy source. PHAs are synthetized intracellularly by 
a cascade of enzymatic reactions (figure 1.1). Upon production, PHAs are accumulated in the form of 
granules in the cytoplasm, surrounded by a monolayer of phospholipids and associated proteins [17, 
23]. PHAs can be composed of numerous monomers, which lends co-polymers of these monomers a 
wide range of physical and thermal properties, including ones that resemble petrochemical-derived 
polymers currently used in the industry, such as polypropylene or polyethylene [23, 24]. Regarding 
monomer size, PHAs can be divided in three categories: short-chain length PHA (scl-PHA), with 
monomers composed of 5 or less carbon units, medium-chain length PHA (mcl-PHA), with monomers 
ranging from 6 to 14 carbon atoms, and long-chain length PHA, with monomers composed of over 14 
carbon atoms. The most common PHAs currently studied are scl-PHA, in which 3-hydroxybutyrate 
(HB) and 3-hydroxyvalerate (HV) monomers are included [23]. Poly(3-hydroxybutyrate) (PHB) is a scl-
PHA homopolymer composed only of HB monomers and is produced by, among others, Cupriavidus 
necator (formerly Ralstonia eutropha H16) [24, 25]. This bacterium has also been described to 
incorporate HV in this polymer, producing a co-polymer poly(3-hydroxybutyrate-co-3-hydroxyvalerate) 
(PHBHV). This co-polymer has increased mechanical properties when compared to PHB (such as 
improved ductility), similar to those of PLA, and is now commercially available [26]. 
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Mixed cultures have also been used to produce PHAs. Advantages of this PHA production method 
include less control steps required for its production, such as sterilization or pH control, and an 
efficient valorization of wastes, which in turn may lower the overall production costs. Other steps may 
be necessary, however, such as transformation of the carbon source, as typical carbohydrate 
substrates may be converted in different products. In such cases, a simple fermentation of the carbon 
source could be used, yielding fatty acids which are preferential for PHA production [27]. Organisms 
that accumulate PHA as a carbon and energy stock are naturally selected from the mixed cultures due 
to their higher adaptability to nutrient variations, and the culture is constantly adapting to the changes 
in the medium. This is especially useful since mixed cultures PHA production was initially thought for 
waste water treatment systems, in which medium variability plays an important role in bacterial 
survival, and accumulated PHA is also a metabolic intermediate to the waste water treatment process 
by these bacteria [28]. PHAs produced by mixed cultures vary according to the feedstock supplied and 
may be homopolymers such as pure PHB, or co-polymers such as P(3-HB-co-3-HV) with reported HV 
contents as high as 82 % [28]. 
The incorporation of PHAs in the industry, however desirable their properties are, is still going at a 
slow pace due to their production costs, most notably the recovery of the polymers. In the laboratory, 
PHA can be obtained with high purity and yield, but most methods employed are undesirable at the 
industry level. PHA is usually extracted from the cells and purified through the use of organic solvents, 
such as chloroform, or using enzymatic or chemical cell wall disruption methods, which impair their 
large scale production due to economic and environmental reasons [23, 25]. 
 
Figure 1.2. Simplified PHA biosynthesis metabolic pathway.  
Adapted from Kunasundari et al. [23]. 
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Some hydrophilic polymers, such as polysaccharides, have the ability to form hydrogels under specific 
conditions. Hydrogels are polymeric structures composed of water-swollen polymers, with varying 
degrees of cross-links [29], whose network may contain up to thousands of times the weight of the dry 
polymer [30]. 
Hydrogels may be classified in multiple ways. As to their network structure, hydrogels may be 
classified as permanent/chemical gels, or reversible/physical gels. Permanent gels are those in which 
the network structure is made by covalent bonding of the cross-links and are usually not homogenous 
as different sites of the gel may contain more or less cross-links (and therefore less or more water 
particles, respectively). Reversible gels are held together by the action of secondary forces, such as 
ionic, hydrogen or hydrophobic forces, as well as molecular entanglements, the latter of which 
contributes to a non-homogenous gel [30]. When these gels are formed by the action of a multivalent 
ion of opposite charge of the polymer, an ionotropic hydrogel is formed. The stability of ionotropic 
hydrogels is very dependent on several factors, such as the valency of the ion used, which will 
determine the cross-links in the gel, as well as the concentrations of the polyelectrolyte and the 
multivalent ion. Furthermore, environmental conditions play an important role regarding the use of 
these gels, as the reversible bonds can be easily broken by changes in the physical conditions of the 
medium such as ionic strength, pH, temperature, pressure or solute competition [30]. 
Other methods of classification of gels exist, such as the number of different components in the gel 
matrix (simple, composed of a single component such as a polysaccharide; mixed, composed of two 
or more components such as two polysaccharides; or composites, in which the matrix is composed of 
two or more different components, such as a polysaccharide and a protein) or by the gelation 
procedure involved, including cold-set, heat-set, ionotropic, pH, or enzyme induced gelation methods 
[31]. 
 
 
Smaller sized particles (micro and nano) have been increasingly studied due to the different 
interesting properties shown when particles reach such scales, especially at nano-scale where size-
dependent properties really come into play, as surface/volume ratio largely increases [32]. 
Biopolymers have been investigated to develop these novel sized structures (beads, spheres and 
capsules), in which different compounds could be encapsulated, including antioxidants, vitamins, pre- 
and probiotics for food applications [33], but also pharmaceuticals for the medical field [34]. 
The preparation of such particles should include the use of non-toxic solvents, be economically 
feasible and account for the properties desired for the matrix, including particle size and shape, 
surface charge and permeability to the encapsulated components. Various methods for the 
preparation of polymeric particles are currently used, including emulsification (blending two immiscible 
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liquids through agitation), extrusion (dropwise addition of a polymeric solution into an ionic solution), 
spray drying (hot air spraying of a solution for quick solvent evaporation), coacervation (electrostatic 
interaction of opposite charged biopolymers) and precipitation (based on a varying capacity of the 
solution to solubilize the biopolymer, using two solutions with different solubilization capacities for the 
polymer) [34]. 
 
 
Polymeric films are thin layers of a polymeric material or blend of materials [35]. Natural polymer films 
have been reported for their good mechanic or barrier properties and were proposed to be used in the 
food industry (in applications such as packaging) or the medical field (as topic drug delivery and 
wound healing systems). Such polymeric films are usually easy to manufacture, cost-effective and 
biocompatible, and sometimes display adhesive properties [36]. 
Regarding porous cell scaffolds for the medical field, several methodologies for film formation have 
been described, including solution casting and solvent evaporation, and particle leaching (consisting of 
a dissolved polymer with insoluble particles suspended on that specific solvent being cast on a surface 
for the evaporation of the solvent, and then washed with a different solvent to remove the particles) or 
emulsion freeze-drying (in which an emulsion of two immiscible liquids, one of which contains the 
dissolved polymer, is freeze-dried) [37]. Other techniques include gas foaming (in which a salt is used 
to release gas particles into the medium under certain conditions, such as temperature, followed by 
freeze drying) or 3D-printing of the scaffold (using CAD designs) [37, 38]. Among porous films for 
biological uses, PHA films (PHB and PHBHV) have been investigated and reported as suitable for 
constructing in vitro matrices [39]. Furthermore, PHB and copolymeric P(3-HB-co-4-HB) have been 
successfully blended with a polysaccharide (bacterial cellulose, BC) and the respective blends (PHB-
BC and P(3-HB-co-4-HB)-BC) have been tested in fibroblasts. The results show that the polyester-
polysaccharide blends produce much better porous matrices for cell adhesion, increasing the number 
of adherent cells when compared to the polyester films alone [40, 41]. 
 
 
As mentioned above, various polymeric structures have been proposed for the medical and 
pharmaceutical fields and were proven quite adept to be used as drug delivery systems or tissue 
regenerating scaffolds. Among such structures, polysaccharide gel particles and polymeric films stand 
out [34, 36]. Mannans are hydrophilic and biocompatible components, with proven interesting 
properties such as immunomodulator, antimicrobial, antiviral, antioxidant, antimutagenic and antitumor 
activity [3, 14, 15]. PHAs are biocompatible polymers with diverse possible arrangements and 
interesting physical and thermal properties, comparable to those of commercially available polymers 
[23, 24]. 
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Nevertheless, any polymer proposed for biological applications must be individually submitted to 
extensive and thorough tests, to evaluate its biocompatibility and cytotoxicity. In vitro tests are 
essential and determinative forefront tests than must be performed to assess a material’s biological 
compatibility. They represent the frontline safety barrier for compounds to reach human (and animal) 
applications, and though they are not representative of complete systems (such as organs or the full 
body), in vitro tests grant researchers relevant insights on how compounds will affect their targets in 
vivo. As such, a proper choice of the cell models and the employed methodologies must be made in 
order for in vitro tests to be representative. 
As such, the objective of this thesis was to produce and extract these polymers from their producing 
organisms (mannans from the cell-wall of the yeast Komagataella pastoris and PHAs from the 
biomass of a mixed microbial culture) and use them to create different structures for biological 
applications. Mannans were tested for their gelling capacity and used to manufacture different gel 
particles using di- and trivalent cations following ionotropic gelation procedures. The produced gel 
particles were tested with different tumoral cell lines and a regular skin fibroblast cell line, in order to 
be potentially used as a drug delivery system for cancer. PHAs and mannans were used to produce 
polymeric films (both alone and blended) and their cytotoxicity and capacity to support cell adherence 
was determined using normal fibroblasts and a tumoral cell line, envisaging their use as drug delivery 
systems or wound dressings. 
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Komagataella pastoris (DSM 70877) was used to produce the polysaccharide in use, mannans. The 
yeast was cultivated in medium K, with the following composition: KH2PO4, 28 g L-1; CaSO4.2H2O, 
0.125 g L-1; MgSO4.7H2O, 2 g L-1; (NH4)2SO4, 13.5 g L-1. Medium K was supplemented with 2 mL L-1 of 
a trace mineral solution, with the following composition: CuSO4.5H2O, 2 g L-1; MuSO4.H2O, 3 g L-1; 
ZuCl2, 7 g L-1; FeSO4.7H2O, 22 g L-1; Biotin, 0.2 g L-1; H2SO4, 5 mL L-1. The pH was adjusted to 5.0 
with NaOH 2 M. 
The inoculum was prepared in four 500 mL shake flasks, adding 1 mL of cryopreserved yeast to each 
of them holding 200 mL of medium K supplemented with 45 g L-1 glycerol (Scharlau, 86-88 % w/w). 
The inoculum was incubated for 40 h at 30 ⁰C and 200 rpm in an orbital shaker (IKA KS 260 basic). 
Medium K and glycerol were sterilized separately by autoclaving (Uniclave 77, Portugal) at 121 ⁰C for 
20 min, and the trace mineral solution was sterilized by filtration (Whatman, 0.2 µm). 
 
 
The production assay was performed in a 10 L bioreactor (BioStat B-plus, Sartorius), with a starting 
volume of 8 L, using medium K prepared as described above (2.1.1.1.1.). The inoculum was added in 
a 10 % (v/v) ratio to the bioreactor. 
The culture was grown in batch mode until the depletion of the carbon source (at around 24 h), at 
which point a fed-batch phase was initiated and kept for the remainder of the assay (26 h). For the 
fed-batch phase, 3430 g of glycerol were used, supplemented with 67 mL of trace mineral solution, at 
a constant flow of 144.64 g h-1. The assay was conducted with controlled temperature (30 ± 0.1 ⁰C), as 
well as controlled pH (5.0 ± 0.02), through the addition of either HCl 2 M or NH4OH 25 % (v/v). The 
dissolved oxygen concentration (pO2, %) was controlled by the automatic adjustment of the stirring 
(between 300 and 1500 rpm) by two six-blade impellers. The setpoint was 15 % of the air saturation. 
Periodic samples (10 mL) were retrieved from the bioreactor for biomass quantification.  
 
 
 
Cell growth was monitored during the experiment by measuring the optical density at 600 nm 
(OD600nm) in a UV-Vis spectrometer (VWR V-1200). The absorbance of the samples was kept under 
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0.3 by dilution of the broth with deionized water. 
 
 
Biomass quantification was performed gravimetrically. The cell dry weight (CDW) was determined by 
treatment of the acquired samples, namely by centrifugation (Sigma, 4-16KS) at 8875 g for 15 min at 4 
⁰C to remove the supernatant, and subsequent washing of the pellet with deionized water. The 
washed biomass was afterwards deep frozen (-80 ⁰C) and freeze dried (Telstar, Cryodos) for 48 h at -
90 ⁰C. The CDW was defined by the resulting weight of the lyophilized pellet. 
 
 
NaOH 2 M was added in a 1:1 (v/v) ratio to the culture broth for an alkali-heat treatment, as previously 
described by Freitas and co-workers [42]. The resulting mixture was heated up to 65 ⁰C, for 2 h under 
constant stirring (400 rpm). After cooling, the mixture was subjected to centrifugation (13131 g, 15 
min, 4 ⁰C) for separation of cell-wall polymers. 
Mannans were recovered from the supernatant (alkali soluble fraction) and dialyzed with a 12000 
MWCO membrane against deionized water at room temperature (20 ⁰C) for 48 h. The dialysis was 
performed under regular water exchanges accompanied by pH and conductivity measurements, being 
stopped at neutral pH (between 6.0 and 7.0) and low conductivity (< 50 µS cm-1). The resulting 
dialyzed polymer was then freeze dried (Telstar, Cryodos) for 48 h at -90 ⁰C. The polymer was kept in 
closed sample containers (30 mL) with screw caps, at room temperature and sheltered from light and 
moisture until use. 
 
 
 
Mannans were analyzed regarding their monomeric composition. Briefly, 5 mg of polymer were 
digested with 2 % trifluoroacetic acid (Sigma-Aldrich, 99 %) in deionized water at 120 ⁰C for 2 h. The 
resulting hydrolysate was diluted (1:5 v/v in deionized water) and filtered (0.2 µm nylon membrane, 
VWR) for high pressure liquid chromatography (HPLC). 
HPLC analysis was conducted using a CarboPac PA10 4x250 mm + Aminotrap column (Dionex) 
equipped with an amperometric detector, using NaOH 18 mM at 1 mL min-1 as eluent, at 25 ⁰C. 
Glucose (Fisher Scientific, 99.5 %), mannose (Sigma-Aldrich, 99.0 %) and glucosamine (Sigma-
Aldrich, 99.9 %) were used as standards in ultrapure water ranging from 1 to 100 µg mL-1, covering 
the concentrations of monomer contents of the mannans samples. 
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Protein content of the samples was determined by a protein precipitation method, using trichloroacetic 
acid (TCA) (Scharlau, 99.5 %). A mixture of 1 g of polysaccharide with 2 g of TCA was made in 
ultrapure water, and the solution was left at 4 ⁰C for 15 min. After the settling period, it was centrifuged 
(7155 g, 15 min, 4 ⁰C) and the protein pellet was separated from the supernatant. The supernatant 
was submitted to the same process until there was no visible pellet formation, after which it was 
dialyzed by the process described above (2.1.1.2.). The various pellets were put together as one, 
repeatedly washed with deionized water, and both pellet and supernatant were freeze dried as 
described in section 2.1.1.2. and sent for elemental analysis. Precipitated protein was quantified 
gravimetrically from the precipitation pellet, and total protein was estimated based on a 6.25 factor of 
total nitrogen found in the sample, a non-specific factor developed by Jones [43]. 
 
 
The moisture content of the polysaccharide was measured gravimetrically, by leaving a predetermined 
amount of mannans to dry in an oven (100 ⁰C) overnight. The polymer weight was then measured and 
left in open air until constant weight (48 h). 
 
 
Mannans inorganic content was determined gravimetrically, by placing a predetermined amount of 
polymer (50 mg), previously dried at 100 ºC for water removal, in an oven (Nabertherm, LE060K1BN 
Compact Muffle Furnace) at 500 ⁰C overnight. The resulting powder was then weighted. The assay 
was done in triplicate. 
 
 
For elemental analysis, a predetermined amount of polysaccharide was delivered as obtained from the 
purification step. Elemental analysis was performed regarding nitrogen, carbon, hydrogen and sulfur 
using an Elemental Analyzer (Thermo Finnigan-CE Instruments, Flash EA 1112 CHNS Series), using 
a Multiseparation Column (SS; 2 m; 6x5 mm). Combustion reactor temperature was of 950 ⁰C and 
sulfanilamide was used as standard, with a composition of 16.26 % N, 41.85 % C, 4.68 % H e 18.62 
% S, using factor K as calibration. 
 
 
Phosphate was analyzed by Inductively Coupled Plasma Atomic Emission Spectroscopy (ICP-AES). 
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Samples were prepared by diluting the polysaccharide (10 mg ml-1) and were then sent for analysis. 
Analysis was performed using an ICP (Ultima model, Horiba Jobin-Yvon, France) equipped with a 
40.68 MHz RF generator and a Czemy-Turner sequential monochromator with 1.00 m and a nebulizer 
(MiraMist). Phosphorus Standard for ICP 1000 mg L-1 (Sigma-Aldrich, Trace-CERT) was used as 
standard, diluted in ultrapure water ranging from 1 to 100 mg L-1. 
 
 
 
Deproteinized mannans were obtained using the protein quantification method described above 
(2.1.1.3.2.), by recovery of the protein-free supernatant followed by dialysis using a 12000 MWCO 
membrane (20 ⁰C, 48 h) and freeze drying (-90 ⁰C, 48 h). The polymer was kept in closed sample 
containers (30 mL) with screw caps, at room temperature and sheltered from light and moisture until 
use. 
 
 
A phosphorylation procedure, adapted from DiLuzio [44], was applied to mannans, in an attempt to 
increase mannans content in phosphorous. Briefly, 1 g of mannans was dissolved in 50 mL DMSO 
and heated up to 100 ⁰C, at which point 10 mL of orthophosphoric acid (H3PO4, Sigma-Aldrich, 85 %) 
were added dropwise, under constant magnetic stirring (400 rpm). The temperature of the reaction 
was maintained for 6 h, after which the solution was allowed to cool at room temperature. After 
cooling, it was dialyzed using a 12000 MWCO membrane (20 ⁰C, 48 h) and freeze dried (-90 ⁰C, 48 h) 
to obtain the phosphorylated polymer. The polymer was kept in closed sample containers (30 mL) with 
screw caps, at room temperature and sheltered from light and moisture until use. 
 
 
 
Polyesters, namely polyhydroxyalkanoates (PHAs), were extracted from previously produced mixed 
cultures dry biomass. Biomass with accumulated PHA was provided by Mariana Matos and Liane 
Meneses from the BioEng group. PHA production occurred in a three-step process: a first step 
consisting in the acidogenic fermentation of a fruit waste pulp (supplied by SumolCompal SA, 
Portugal) into organic acids and ethanol, used as carbon source for the production of PHAs; a second 
step consisting of a Feast and Famine feeding mode to select PHA accumulating bacteria; and a third 
step, where the selected microorganisms were fed the resulting carbon source from the acidogenic 
fermentation process in a pulse feeding mode (controlled by DO), under limiting nitrogen conditions to 
impair cell growth [28]. The third step was conducted in a 10 L bioreactor for the production of PHA 
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with 17 % HV content, and in 50 L bioreactors for the production of PHAs with 18, 27 and 38 % HV 
contents.  
The extractions occurred using a Soxhlet extractor (250 mL extractor, Lenz-Laborglasinstrumente), in 
which a biomass filled cartridge (working as a thimble) was placed inside the main chamber of the 
apparatus (holding 5 g of dry biomass), and chloroform (Honeywell, 99.4 %) was used as solvent (250 
mL). The extraction period was of 24 h at 90 ⁰C. After the extraction, the solution was recovered, 
containing both the polyester and membrane lipids dissolved in chloroform. The purification process 
consisted of pouring the solution dropwise in glacial ethanol (Carlo Erba, 99.9 %) in a 10 % (v/v) ratio 
to remove the lipidic fraction of the sample. Lipids dissolved in ethanol, while the polyester turned 
insoluble and precipitated. The extraction solvent/ethanol mixture was submitted to repeating freeze-
thaw cycles (-20 ⁰C for 4 h) to ensure maximum precipitation of polyester. The polymer was then 
removed from the mixture and left to dry inside the fume hood at room temperature. PHAs with 
different compositions were obtained, namely co-polymers of 3-hydroxybutyrate (HB) and 3-
hydrovalerate (HV) with varying HV contents (ranging from 17 % HV to 56 % HV). 
 
 
 
Gelation procedures were tested using mannans. In a preliminary phase, it was tested the effect of 
pH, temperature and salt addition, in various crossed experiments. Individual mannans solutions (50 
mg ml-1) were submitted to different pH values (1.9, 5.6 and 9.6) at 4 ⁰C for 96 h, as well as pH 5.6 at 
autoclave temperature (121 ⁰C) for 20 min, followed by 96 h at 4 ⁰C. In a secondary experiment, 
different salts were added to fresh mannans solutions (50 mg mL-1) at the three tested pH values, 
namely FeCl2.4H2O (Sigma-Aldrich, 99.0 %), CuCl2.2H2O (Sigma-Aldrich, 99.0 %) and CaCl2 
(PanReac AppliChem, 95 %) at 20 mg mL-1, and the solutions were kept at 4 ⁰C for 72 h. 
In a second phase, fresh mannans solutions (10 % (w/w)) were set at pH 5.5, 7.4, 9.4 and 11.4, and 
for each pH different concentrations (from 10 to 50 mg mL-1) of the previously used salts were tested. 
Samples were kept at 4 ⁰C and evaluated periodically over 144 h. 
In both phases, mannans solutions were prepared using deionized water and the pH was set using 
either HCl 2 M (Fischer Scientific, 37 %) or NaOH 2 M (EKA, 97 %). 
The third phase of the gelation procedures was the obtainment of gel structures. Six different versions 
of this experiment were performed, using either CuSO4.5H2O (Riedel-de Haën, 99.0 %) or FeCl3.6H2O 
(Sigma-Aldrich, 98.0 %), as follows: 
1) Dropwise addition of mannans solution (10 % (w/w) in H20) to a CuSO4 50 mg mL-1 solution; 
2) Dropwise addition of mannans solution (10 % (w/w) in H20) to a FeCl3 50 mg mL-1 solution; 
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3) Dropwise addition of mannans (10 % (w/w) in H20) and CuSO4 50 mg mL-1 solution to a NaOH 
2 M solution; 
4) Dropwise addition of mannans (10 % (w/w) in H20) and FeCl3 50 mg mL-1 solution to a NaOH 
2 M solution; 
5) Dropwise addition of mannans solution (10 % (w/w) in NaOH 2 M) to a CuSO4 50 mg mL-1 
solution; 
6) Dropwise addition of mannans solution (10 % (w/w) in NaOH 2 M) to a FeCl3 50 mg mL-1 
solution. 
The dropwise addition of the mannans solution (1 mL) was made using sterile needles 
(HenkeSassWolf, Fine-Ject, 23 G – 0.6 x 25 mm) into 30 ml of the cation solution. The structures 
obtained were left under stirring for 30 min and were then washed using deionized water (30 mL) for 
removal of excess salt and lowering of the pH value, controlled by measurement of pH (until neutral 
pH) and conductivity (until below 50 µS cm-1). The structures were then freeze dried (-90 ⁰C, 48 h) and 
weighted. Version 4 was also repeated twice, in which the washing process was changed to either 
centrifugation (7155 g, 10 min, 4 ⁰C) or dialysis against deionized water (20 ⁰C, 24 h). In either case, 
the structures were then freeze dried (-90 ⁰C, 48 h) and weighted. 
 
 
For preparation of mannans films, 500 mg of the polymer were dissolved in 5 mL of deionized water, 
at room temperature, under magnetic stirring (300 rpm) until complete dissolution. Two other variants 
of the above were performed, one to which 50 mg of glycerol (Scharlau, 86-88% w/w) were added, 
and another to which 50 mg of polyethylene glycol 4000 (PEG) (Fluka, Sigma-Aldrich) were added. 
These two components were used as plasticizers, to account for the natural brittleness of the 
polymeric films. The solutions were cast on Teflon plates (50 mm), and the solvent was left to 
evaporate in an oven (Raypa) at 30 ⁰C for 120 h (figure 2.1 A). 
In a second stage, 1 g of mannans was dissolved in 5 mL of deionized water, at room temperature, 
under magnetic stirring (300 rpm). This procedure was repeated, with the addition of 50 mg PEG, and 
both films were left to dry in an oven (Raypa) at 30 ⁰C for 120 h. A third variant was performed as was 
the first (1 g mannans in 5 mL deionized water) but was instead freeze dried (-90 ⁰C, 48 h) (figure 2.1 
B). The first and the third variant of this assay were reproduced in plastic petri dish scale (Labbox, 90 
mm diameter) as well as cell culture plates (VWR, 35 mm diameter) at 10 % (w/w). The first variant 
(petri dish) was then used to mimic some procedures developed for gelation purposes. One piece of 
film was placed in a FeCl3 50 mg mL-1 solution for 2 h, and then relocated to a NaOH 2 M solution for 
2 h. Another piece was placed in a FeCl3 50 mg mL-1 solution for 2 h, and the final piece was placed 
inside a NaOH 2 M solution for 2 h. All three pieces of film were later washed with deionized water to 
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either lower pH (up until neutral pH) and/or conductivity (below 30 µS cm-1) (figure 2.1 C). 
Also, films performed using iron gelling structures (2.2.1, version 4) dried in cell culture plates (both in 
an oven at 30 ⁰C and by freeze drying at -90 ⁰C for 48 h) were obtained (figure 2.1 D). 
A comprehensive scheme regarding mannans films is presented in figure 2.1.  
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Figure 2.1. Film formation procedures.  
(A) and (B) represent early stages of film formation, in which plasticizers (glycerol and PEG) were tested, and 
films were cast on Teflon plates. (C) represents version 1 and 3 of figure B (left and right arrows, respectively) 
being cast on both petri dish and cell culture plates, as well as the transformations employed on the petri dish film 
(30 ⁰C, 120 h). (D) represents films performed using iron gelling structures. Red “X” marks non-used films, 
whereas “Biological Assays” marks films used for posterior cell adherence assays.  
 
In a later stage, films of both polyester alone and in conjunction with mannans were prepared, by 
dissolving both polymers and allowing the solvent to evaporate inside a desiccator (Schott, 
Vakuumfest) in the fume hood at room temperature. Firstly, two methods were tested, in which PHB 
was dissolved in chloroform and mannans were either dissolved in deionized water or suspended in 
the PHB solution in chloroform. The second method was used in later assays. Secondly, an assay for 
optimal PHB/mannans ratio was conducted, testing the two polymers at different ratios, namely 25/75 
% (w/w), 50/50 % (w/w) and 75/25 % (w/w), the latter of which was chosen for the final tests. 
The various PHA co-polymers obtained (150 mg), with HV contents comprehending 0 % (HB 
homopolymer), 17 %, 18 %, 27 %, 38 % and 56 % HV (w/w), were then dissolved in 10 mL of 
chloroform (alone – 100 % (w/w) PHA; or alongside mannans – 75/25 % (w/w) PHA/mannans ratio) 
under magnetic stirring (500 rpm) and allowed to dry inside a desiccator (Schott, Vakuumfest) in the 
fume hood, at room temperature. 
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Three adherent cell lines (colorectal carcinoma cell line – HCT116; ovarian carcinoma cell line – 
A2780; normal human skin fibroblasts) were purchased from American Type Culture Collection 
(ATCC®), and one adherent cell line (modified breast adenocarcinoma cell line – MCF7-GFP) was 
purchased from Cell Biolabs Inc (San Diego, CA, USA). HCT116 and normal fibroblasts were grown in 
Dulbecco’s Modified Eagle Medium (DMEM) (Gibco, Life Technologies, USA), supplemented with 10 
% (v/v) FBS (Gibco, Life Technologies, USA) and 1 % (v/v) antibiotic/antimycotic solution (Invitrogen). 
MCF7-GFP was grown in DMEM (as above) supplemented with an additional 1 % (v/v) MEM non-
essential amino acids (Gibco, Life Technologies, USA). A2780 was grown in Roswell Park Memorial 
Institute (RPMI) medium (Gibco, Life Technologies, USA) supplemented with 10 % (v/v) FBS and 2 
mM glutamine. All cultures were maintained in an incubator (SANYO, CO2 Incubator, Electrical 
Biomedical CO., Osaka, Japan) at 37 ⁰C, with an atmosphere of 5 % (v/v) CO2 and 99 % (v/v) relative 
humidity (RH). 
 
 
Cytotoxicity assays were performed for both mannans and its deproteinized version, in HCT116, 
A2780 and normal fibroblasts. The three cell lines were independently seeded in 96-well plates (VWR, 
Radnor, Pennsylvania, USA) at a density of 0.75 x 105 cells per well and left to adhere for 24 h in an 
incubator at the conditions described above. After 24 h, seeding medium was replaced with fresh 
medium containing either regular or deproteinized mannans (0 – 2000 µg mL-1) or control components 
(0.4 µM of doxorubicin (DOX), 0.4 µM of dimethyl sulfoxide (DMSO), TCA 0.5 % (w/v)) and left for 48 h 
in the same conditions. After 48 h, both polysaccharide and control loaded media were replaced with 
fresh medium containing 20 % (v/v) Cell Titer 96 ® AQueous Non-Radioactive Cell Proliferation Assay 
Kit (Promega, Madison, USA) (composed by 3-(4,5-Dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-
2-(4-sulfophenyl)-2H-tetrazolium (MTS inner salt) and phenazinemethosulfate (PMS, coupling 
reagent)). After a new incubation for 45 min (under the conditions described above), absorbance 
measurement at 490 nm was performed for each well using Tecan Infinite F200 Microplate Reader 
(Tecan, Männedorf, Switzerland). Cell viability (%) is given by (Eq. 1): 
Eq.1 
 
A cell density of 0.75 x 105 cells per well was achieved by Trypan Blue Exclusion method. Cells were 
centrifuged at 500 g and resuspended in 1 mL of appropriate medium, followed by dilution to 10 % 
(v/v) alongside Trypan Blue reagent (Sigma, St. Louis, USA) 20 % (v/v) in the same growth medium. 
This solution was inserted in a hemocytometer (Hirschmann, Eberstadt, Germany), and cell count was 
performed by microscopic observation of viable cells using an Olympus CXX41 inverted microscope 
(Tokyo, Japan). Cell density (cells mL-1) is given by (Eq. 2): 
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Eq. 2 
 
 
 
Cell adherence assays were performed for previously described films using either normal skin 
fibroblasts or MCF7-GFP. Cell line MCF7-GFP was used due to microscopic observation constrains 
when using normal skin fibroblasts, as the films opacity cloaked the visualization of these cells. MCF7-
GFP produces Green Fluorescent Protein (GFP), whose fluorescence was used to overcome the 
visualization constraints. Mannans films (regular mannans films (dried at 30 ⁰C or freeze dried), iron 
gelling structure films (dried at 30 ⁰C or freeze dried), and films obtained from manipulation of 
mannans film to mimic gelation procedure methods (first and second pieces, both dried at 30 ⁰C)) 
were tested using regular fibroblasts. These films were prepared inside the cell culture plates (VWR, 
35 mm), and sterilized using UV light for 30 min. A cell suspension of 0.75 x 105 cells mL-1 was 
prepared and added to the films (1 mL per plate) and incubated for 24 h (at 37 ⁰C, 5 % (v/v) CO2, 99 % 
(v/v) RH) for cell adhesion. After 24 h, cell adhesion was verified using a fluorescence inverted 
microscope (Nikon Eclipse Ti), (Nikon, Intensilight C-HGFI). 
PHA/mannans films were tested using both skin fibroblasts and MCF7-GFP. These films were 
prepared in separate glass vessels, sterilized in autoclave (121 ⁰C, 30 min) and inserted in cell culture 
plates. The following procedure was identical to that used for mannans films. 
Cell viability assays were also performed with pure PHA films on adherent cells. MCF7-GFP were 
seeded on top of pure PHA films in cell culture plates (VWR, 35 mm) at a density of 0.75 x 105 cells 
per plate, and incubated for 48 h at 37 ⁰C, with an atmosphere of 5 % (v/v) CO2 and 99 % (v/v) RH. 
After the 48 h incubation period, seeding medium was replaced with fresh medium containing 15 % 
(v/v) Cell Titer 96 ® AQueous Non-Radioactive Cell Proliferation Assay Kit (Promega, Madison, USA), 
and subsequently incubated for 1 h at the same conditions, after which absorbance measurement at 
490 nm was performed for each plate using Tecan Infinite F200 Microplate Reader (Tecan, 
Männedorf, Switzerland). 
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The bioreactor was operated in batch mode for the first 24 h, after which it was switched to a fed-batch 
mode for the remainder of the assay. Carbon source for the fed-batch mode was supplied at a 
constant rate of 116.84 mL h-1 (144.64 g h-1). During the exponential phase, yeast biomass grew at a 
specific cell growth rate of 0.17 h-1 similar to that found in literature for Komagataella pastoris grown in 
glycerol by Roca and co-workers [11], reaching a maximum CDW value of 166.88 g L-1 at 50 h of 
cultivation (Figure 3.1). 
Mannans content was determined to be 37.75 % (w/w) of CDW and the volumetric productivity was 
calculated to be 1.25 g L-1 h-1. The growth yield was 0.42 gbiomass gglycerol-1, lower than that described for 
pure glycerol, 0.55 gbiomass gglycerol-1 as described by Roca and co-workers [11]. This discrepancy could 
be due to glycerol that was administered to the bioreactor but which ended up not being consumed by 
the yeast. However, since glycerol was not quantified at the end of the assay, this hypothesis cannot 
be confirmed. The product yield was of 0.13 gmannans gglycerol-1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1. Cell Dry Weight over the course of the bioreactor assay. 
 
 
 
 
Monomeric analysis of the produced mannans revealed a mannose content of 24.13 ± 2.04 % w/w. 
Traces of glucose (2.27 ± 0.02 % w/w) and glucosamine (0.78 ± 0.01 % w/w) were also detected. 
Glucosamine is a characteristic monomer of CGC and the fact that it was present in the sample could 
be proof that the extraction process was not 100 % effective, as purified mannans should not have any 
trace of it. This fact misleads the calculation of true monomeric content of the sample, both by 
underestimating the mannose content (which should be higher) and overestimating the glucose 
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content (which may as well be part of the CGC fraction present in the sample). 
 
 
Protein quantification was achieved by a protein precipitation method using TCA as a precipitation 
agent. The total protein precipitated was as high as 19.45 ± 0.53 % (w/w). This amount of precipitated 
protein, however, does not encompass all the initial protein in the sample, as discussed below (3.2.5). 
The precipitation process also depleted the sample of about half of its remaining polymeric content, as 
only 41.19 ± 1.73 % (w/w) of the initial sample was able to be retrieved, which had a mannose content 
of 24.13 ± 2.04 % w/w. This is most likely due to hydrolysis effect caused by the TCA, as the 
carbohydrate sidechains of the mannoprotein fraction of the sample were too small and therefore able 
to cross the pore of the dialysis membrane. It is also possible that non-mannoprotein mannans were 
hydrolyzed into smaller polysaccharides. 
 
 
Moisture content of the mannans sample was determined to be 5.08 % (w/w). 
 
 
Inorganic content of the mannans sample was determined to be 1.46 ± 0.09 % (w/w). 
 
 
Elemental analysis was performed for mannans as obtained, deproteinized mannans as well as the 
deproteinization pellet. Results are displayed in table 3.1. 
Table 3.1. Elemental analysis of mannans.  
 
Element % (w/w) 
Nitrogen Carbon Hydrogen Sulphur 
Mannans 6.90 ± 0.09 43.76 ± 0.01 6.86 ± 0.28 0 
Deproteinized Mannans 2.09 ± 0.02 41.42 ± 0.06 6.63 ± 0.03 0 
Protein Pellet 10.98 ± 0.06 57.45 ± 0.08 8.23 ± 0.26 0.30 ± 0.03 
Results are presented as Mean ± SD (%). 
The results show a total of 6.90 ± 0.09 % (w/w) nitrogen content, corresponding to a protein content of 
42.71 ± 0.19 % (w/w). Protein quantification was performed based on a 6.25 factor as previously 
described (2.1.1.3.2). 
There was a total carbon content of 43.76 ± 0.01 % (w/w) in the mannans sample. 
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Phosphate content was determined for samples of original, deproteinized and phosphorylated 
mannans as well as for the phosphorylation pellet. Results are shown in table 3.2. 
 
Table 3.2. Phosphate and ammonia content of mannans.  
 Phosphate % (w/w) 
Mannans 1.97 ± 0.17 
Deproteinized Mannans 1.31 
Phosphorylated Mannans 1.04 ± 0.04 
Phosphorylation Pellet 0.59 
Results are presented as Mean ± SD (%). 
Regarding phosphate content, analysis was performed by ICP-AES). Phosphate content was 
determined to be 1.97 ± 0.17 % (w/w) in the original polymer. Phosphate content was determined due 
to its relevant role in numerous biological processes, as phosphorylated polysaccharides (both 
naturally occurring and transformed) have been described to have enhanced immunocompetence, 
anticoagulation and antineoplastic activity [45], as well as antitumor activity [3]. The content in 
phosphate as also been related to its activity, both immunochemical and serological [46, 47]. The 
phosphate content of the mannans in this study is within range from mannans obtained from different 
yeasts, namely C. albicans, which have reported values typically ranging from 0 to 2.4 %, although 
higher phosphate content values have been reported, almost up to 5 %, depending on cultivation 
conditions [48]. Other studies on P. holstii showed that certain fractions of polysaccharides may be 
even richer in phosphate contents (from 3 to 7.4 %) [49], although the complete mannans profile may 
not be present. Although many reported phosphomannans contain lower amounts of phosphate than 
the one in this study, phosphate content is a relevant factor for the desired properties, and thus an 
attempt to increase it was made (3.3.2). 
 
 
 
 
As described above (3.2.2), deproteinized mannans were obtained from the supernatant of the protein 
precipitation method, with a yield of 41.19 ± 1.73 % (w/w) for recovered polymer and a yield of 69.49 ± 
0.44 % for removed protein. From the results of elemental analysis (table 3.1), it is possible to see that 
the TCA precipitation method did not remove all the protein from the initial sample, but total protein 
precipitated was higher than the previously calculated (3.2.2), totalling 29.68 ± 0.32 % (w/w). The 
protein precipitation method employed, using TCA, has been described as a high yielding precipitation 
method, with precipitation yields above 90 % for removed protein [50], well above those described in 
this study. Moreover, polymer recovered in that study was higher than the one reported here, with a 
total loss of polymer of 19 %. This shows that the TCA method employed, while effective in removing 
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proteins from mannans samples, is still requiring tuning to increase protein precipitation, as well as 
diminish wasted polymer. 
There was a total carbon content of 41.42 ± 0.06 % (w/w) in the deproteinized sample and 57.45 ± 
0.08 % (w/w) in the protein pellet (table 3.1). 
Phosphate content in the deproteinized polymer was of 1.31 % (w/w) (table 3.2).  
 
 
The phosphorylation procedure applied to mannans had a final yield of 29.72 % (w/w) for recovered 
polymer, despite the results presented above (3.2.6, table 3.2) regarding its content in phosphate, 
which would render a negative yield (loss) in terms of total phosphate in the polymer, of -46.64 ± 6.63 
% (w/w). The method employed in the phosphorylation of mannans was adapted from a 
phosphorylation procedure of glucans [44], in which the author achieved a total of 2.23 % of 
phosphorylation after 6 h of reaction, with a total polymer recovery between 70 and 90 %. Other 
authors using a similar method described a total yield for recovered polymer below that achieved in 
this work, of 24.8 %, and postulated that the conditions of the experiment, and the type and ratios of 
the reagents could account for significant yield variability [51]. A different method was reported to 
generate a phosphorylated polysaccharide with a phosphate content as high as 14.36 % [45]. 
It is clear to see the diminishing in phosphate content from the original polymer to either of the 
transformed polysaccharides, remarkably so to the one submitted to a phosphorylation process. Not 
only was the phosphorylation unsuccessful, it reduced the sample content in phosphorous, most likely 
due to the concentration of phosphoric acid, which ended up hydrolyzing the sample much more than 
it added any phosphate groups. Other causes may be related to the method itself, as it was adapted 
from a phosphorylation procedure of insoluble glucans, and certain modifications were made 
regarding the soluble nature of mannans, namely the use of urea as a chaotropic agent. 
Phosphate content of the sample showed a total of 1.04 ± 0.04 % (w/w) in the phosphorylated polymer 
and 0.59 % (w/w) in the phosphorylation pellet. 
 
 
Different PHAs were used, with varying monomeric composition in terms of hydroxybutyrate (HB) and 
hydroxyvalerate (HV). The PHAs used include PHB (100 % HB monomers), PHBHV17 (83 % HB, 17 
% HV), PHBHV18 (82 % HB, 18 % HV), PHBHV27 (73 % HB, 27 % HV), PHBHV38 (62 % PHB, 38 % 
HV) and PHBHV56 (44 % HB, 56 % HV). 
All polymers except PHBHV18 were extracted with chloroform with a Soxhlet apparatus and purified 
by precipitation in cold ethanol. PHBHV18 was first extracted with hypochlorite (bleach) and 
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subsequently it was purified to remove any trace amounts of the solvent, for biological applications.  
 
 
 
As previously described (2.2.1), gelation procedures were only performed using mannans. In the 
preliminary phase, pH and temperature were the main focus, with a small insight on salt effect. 
Temperature was the first variable to be refined, as gel formation only started to occur at low 
temperatures (4 ⁰C). No gel formation was visible at room temperature, and at higher temperatures 
(121 ⁰C) the solution resulted in a turbid, granulated precipitate upon cooling. pH was also pre-refined, 
as acidic pH (pH 1.9) had a negative effect in the solution (high turbidity and no gel formation) both in 
the presence and absence of different salts (FeCl2, CuCl2 and CaCl2). Neutral and alkaline pH (pH 5.6 
and 9.6) displayed a beneficial effect (increased viscosity and clearness of the solution) when 
combined with the different salts used. Preliminary results are displayed in tables 3.3 and 3.4. 
Table 3.3. Effect of pH and temperature on mannans solutions gelation.  
pH 
Temperature 
4 ⁰C 20 ⁰C 121 ⁰C 
1.9 - - n.a. 
5.6 + - pp 
9.6 + - n.a. 
Results are displayed as (-, no gel formation; +, increased visosity; pp, precipitate; n.a., not available/ not tested). 
Table 3.4. Effect of pH and salt presence on mannans gelation at 4 ⁰C.  
pH 
Salt 
FeCl2 CuCl2 CaCl2 
1.9 - - - 
5.6 + + + 
9.6 + + + 
Results are displayed as (-, no gel formation; +, gel formation). 
Salt effect was further tested using an array of different pH (both neutral and alkaline, pH 5.5, 7.4, 9.4 
and 11.4) and incremental concentrations (10 mg mL-1) of the three different salts (from 10 to 50 mg 
mL-1), and were kept at 4 ⁰C, as displayed in table 3.5 and figure 3.2. Calcium salts were deemed the 
most unstable, despite the fact that gel formation was still evident. This is due to the low resistance of 
the resulting gel to mild agitation which seemed irrespective to either pH or salt concentration used. 
Both iron and copper salts were considered effective in this assay, in all pH and salt concentrations 
tested. Notably, these were much more resistant to mild agitation and only reverted to their original 
state under constant agitation and temperature raise to room temperature. This reversion effect was 
also conditioned by the pH and salt concentration, as higher values of either these variables delayed 
the reversion process. Also, two distinct phases were observable in all gels formed, most likely caused 
by water syneresis from the gel. 
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Table 3.5. Effect of pH and salt concentration on mannans gelation at 4 ⁰C.  
Results are presented as (+, weak gel; ++, strong gel). 
Salt 
Concentration 
(mg mL-1) 
pH 
5.5 7.4 9.4 11.4 5.5 7.4 9.4 11.4 5.5 7.4 9.4 11.4 
10 + + + + + + + + + + + + 
20 + + + + + + + + + + + ++ 
30 + + + + + + + ++ + + ++ ++ 
40 + + + + + + ++ ++ + ++ ++ ++ 
50 + + + + + + ++ ++ + ++ ++ ++ 
 CaCl2 CuCl2 FeCl2 
 
 
 
 
 
 
 
 
 
 
Figure 3.2. Effect of pH and salt concentration on mannans gelation at 4 ⁰C.  
The various solutions in the figure correspond, in the same order, to the entries in table 3.5 
above. 
 
After selection of temperature, pH conditions and salts to test, a new phase began regarding the 
formation of structured gel particles, as previously described (2.2.1), by six different versions of the 
same experiment. Versions differ from each other regarding the order of the addition of the 
components, pH and salt used, as displayed in table 3.6 alongside the main results. Images from the 
resulting beads are displayed in figure 3.3. 
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Table 3.6. Different versions employed for structured gel particles formation.  
 
Version 
Solutions in Syringe Stirring 
Solution 
Bead 
Shape 
Stability 
Sol. 1 Sol. 2 Agitation  Wash Degradation 
1 
Mannans 
10 % (w/w) 
x 
CuSO4 
0.2 M 
Ring -- -- -- 
2 
Mannans 
10 % (w/w) 
x 
FeCl3 
0.185 M 
Ring -- -- -- 
3 
Mannans 
10 % (w/w) 
CuSO4 
0.2 M 
NaOH 
2 M 
Spherical + -- - 
4 
Mannans 
10 % (w/w) 
FeCl3 
0.185 M 
NaOH 
2 M 
Spherical ++ + + 
5 
Mannans 
10 % (w/w) 
NaOH 
2 M 
CuSO4 
0.2 M 
Spherical -- + + 
6 
Mannans 
10 % (w/w) 
NaOH 
2 M 
FeCl3 
0.185 M 
Ring, 
Spherical 
-- + + 
   In Sol. 2 column, x means absent. Results are presented as (--, very susceptible; -, susceptible; +, resistant; ++,  
   very resistant). 
 
 
Figure 3.3. Beads resulting from different versions employed for structured gel particles formation.  
(A) Beads immediately after dropwise addition (in stirring solution); (B) Beads after washing process (in deionized 
water). Versions are indicated on top of the respective (A) figure. 
 
Version 1 consisted in a dropwise addition of mannans solution (10 % (w/w) in H20) into a CuSO4 0.2 
M solution under stirring. The resulting structures were ring shaped (figure 3.3-1A), and very 
susceptible to mild agitation and washing, degrading into small insoluble particles of varying shape 
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and size (figure 3.3-1B). 
Version 2 consisted in a dropwise addition of mannans solution (10 % (w/w) in H20) to a FeCl3 0.185 
M solution. The obtained structures were ring shaped, but degraded into a polymeric cloud, devoid of 
any individual shape under mild agitation (figure 3.3-2A). After washing only few polymeric insoluble 
debris remained (figure 3.3-2B). 
Version 3 consisted in a dropwise addition of mannans (10 % (w/w) in H20) and CuSO4 0.2 M solution 
to a NaOH 2 M solution under stirring. Structures obtained with this method were spherical and more 
resistant to mild agitation (figure 3.3-3A). However, as in version 1, the formed structures were 
susceptible to degrading during washing, yielding small insoluble particles after reaching neutral pH 
and low conductivity (figure 3.3-3B). 
Version 4 consisted in a dropwise addition of mannans (10 % (w/w) in H20) and FeCl3 0.185 M 
solution to a NaOH 2 M solution. The resulting structures were spherical and much more resistant to 
mild agitation and washing process than any other structures (figure 3.3-4A). They retained their 
spherical structure with little aggregation after the washing process (figure 3.3-4B) and only started 
degrading after a few hours in deionized water. 
Version 5 consisted in a dropwise addition of mannans solution (10 % (w/w) in NaOH 2 M) to a CuSO4 
0.2 M solution. Structures formed were spherical but, unlike version 3, were not more resistant to mild 
agitation than version 1 structures (figure 3.3-5A). These were, however, more resistant to the 
washing process, degrading only after a few hours in deionized water (figure 3.3-5B). 
Version 6 consisted in a dropwise addition of mannans solution (10 % (w/w) in NaOH 2 M) to a FeCl3 
0.185 M solution. The structures obtained were irregular, both spherical and ring shaped (figure 3.3-
6A), and degraded with mild agitation (figure 3.3-6B), yet retaining their shape for a few hours after the 
washing period. 
These experiments evidenced the role of alkaline pH in the formation of the beads, namely their 
shape, as neutral pH formed ring shaped (flat) structures and alkali pH induced the formation of 
spherical structures. Also, the order of the addition of the components had an impact in their final 
stability, as a polymer and salt mixture being dropped onto a NaOH solution rendered more stable 
beads. Furthermore, trivalent iron seemed to have an increased effect over divalent copper in the 
resistance of the structured gel, as opposed to divalent iron used in the previous experiment, which 
displayed similar results to divalent copper. 
Considering both shape and stability, version 4 of this experiment was selected, and different washing 
processes were attempted, aiming at reducing its impact in the time the structures lasted in deionized 
water (degradation). Centrifugation reduced the number of intact spheres after the washing process, 
yet a few were still visible, whereas dialysis degraded the spheres even before the end of the process. 
A simple deionized water washing was therefore deemed the most effective, and the resulting beads 
were placed in cell culture plates and laid aside for film formation. 
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In an early stage, mannans films were performed in deionized water (plain, with glycerol and with 
polyethylene glycol 4000 (PEG)), cast in Teflon plates and left to evaporate in an oven at 30 ⁰C. 
Mannans films obtained in Teflon plates are displayed in figure 3.4. The plain mannans films obtained 
were rigid and brittle and broke into small pieces at the time of removal from the Teflon plate (figure 
3.4 A). The glycerol version never fully dried and at the time of its removal from the Teflon plate it lost 
its integrity, forming a paste, and ended being discarded from further tests (figure 3.4 B). This paste 
effect could be due to the fact that glycerol is hydrophilic and has the capacity to retain water 
molecules inside the film, which is an important part of its plasticizer ability [52]. The PEG version was 
also brittle and rigid, breaking into small pieces at the time of its recovery from the Teflon plate (figure 
3.4 C). Regarding the frailness of the obtained films (pure and PEG), an increase in polymer was also 
tested to increase the thickness of the film, but to no avail, as the results were similar (figures 3.4 D 
and E, respectively). Since PEG added little to no improvement to the film formation, it was discarded 
from further uses. 
A new method was then attempted, in which mannans were dissolved in deionized water but the 
removal of the solvent occurred by freeze drying (-90 ⁰C, 48 h). The film formed in this manner had a 
higher volume (and consequent, a higher porosity), was less frail than its previous counterpart and 
was successfully removed from the Teflon plate (figure 3.4 F). The mannans film formation process 
was repeated in two different scales, in petri dish (90 mm diameter) (figures 3.5 B and C) and in cell 
culture plate (35 mm diameter) (figure 3.5 A) scale, regarding both solvent removal methods, in 
perfectly flat surfaces (since the Teflon plates used were slightly convex, resulting in a thinner central 
disk of the film). The resulting films seemed unaffected by the flat nature of the plates tested, 
displaying similar properties to the ones obtained in Teflon plates (figure 3.5). 
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Figure 3.4. Early stage mannans films obtained in teflon plates.  
(A) plain mannans film (30 ⁰C); (B) mannans film with glycerol (30 ⁰C); (C) mannans film with PEG (30 ⁰C); (D) 
plain mannans film (higher concentration) (30 ⁰C); (E) mannans film with PEG (higher concentrations) (30 ⁰C); (F) 
plain mannans film (-90 ⁰C). 
 
 
Figure 3.5. Plain mannans films obtained in petri dish and cell culture plate scale.  
(A) mannans film obtained in cell culture plate (30 ⁰C); (B) mannans film obtained in petri dish (30 ⁰C); (C) 
mannans film obtained in petri dish (-90 ⁰C). 
 
Films obtained in the cell culture plates were laid aside for biological assays (original mannans dried in 
oven – MnOri30; original mannans freeze dried – MnOri-90), and the film obtained in petri dish scale 
(dried in oven at 30 ⁰C) was used to mimic the gelation procedures tested (using iron salt) for bead 
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formation. This film was divided, and each piece suffered a different treatment, one placed in a FeCl3 
0.185 M solution for 2 h (MnOriFeFilm), another placed in a NaOH 2 M solution for 2 h, and a third 
piece placed in a FeCl3 0.185 M solution for 2 h and then relocated to a NaOH 2 M solution for 2 h 
(MnOriFeNaOHFilm). The purpose of these treatments was to turn the mannans film insoluble, 
following selected procedures used to make seemingly insoluble beads. The treatments tested revolve 
around the version 4 procedure (3.5.1), which yielded the best results. Since the mannans film is a 
compact structure rather than a solution, iron and mannans could not be mixed. Instead, the film was 
soaked in the iron solution and then allocated to a NaOH solution. Two other treatments were 
employed, one similar to version 2 (3.5.1) in which the film was only immersed in the iron solution, and 
another in which the film was only immersed in a NaOH solution. These last two treatments were used 
to verify if either of the parts of the first treatment could improve the film insolubility alone. The piece 
placed only in NaOH 2 M dissolved completely, but the other two pieces were washed to remove 
excess salt and to lower pH (until neutral pH and conductivity lower than 30 µS cm-1), placed in cell 
culture plates, dried in an oven (30 ⁰C), and laid aside for biological assays. 
The beads obtained by version 4 (3.5.1) were also used for film formation, by drying in an oven at 30 
⁰C (MnOriFeBeads30) or by freeze drying at -90 ⁰C for 48 h (MnOriFeBeads-90) and were laid aside 
for biological assays. 
All mannans films hereby marked as “laid aside for biological assays” are displayed in table 3.7. 
Table 3.7. Mannans films prepared for biological assays. 
Films Provenance Drying Method 
MnOri30 Cell culture plate Film Oven (30 ⁰C) 
MnOri-90 Cell culture plate Film Freeze-Dry (-90 ⁰C, 48 h) 
MnOriFeFilm Petri dish Film + Version 2 (3.5.1) Oven (30 ⁰C) 
MnOriFeNaOHFilm Petri dish Film + Version 4 (3.5.1) Oven (30 ⁰C) 
MnOriFeBeads30 Version 4 beads (3.5.1) Oven (30 ⁰C) 
MnOriFeBeads-90 Version 4 beads (3.5.1) Freeze-Dry (-90 ⁰C, 48 h) 
 
 
The polyesters obtained were also used to prepare films. Firstly, two different methods were tested 
(figure 3.6), consisting of dissolving PHAs in chloroform and 1) mannans in water and mixing both 
solutions to form an emulsion (figure 3.6 A), or 2) suspending mannans in powder form in chloroform 
(figure 3.6 B). The water/chloroform method was performed to test the capacity for the formation of an 
emulsion between the two phases containing the different polymers. An emulsion was achieved, but 
the differential evaporation of the two solvents caused segregation of the polymers, and the films 
obtained were highly irregular and irreproducible, with mannans clustered on a side from top to bottom 
of the film, making them impossible to be removed whole (figure 3.6 A). However, when mannans 
were suspended in chloroform for film formation, solvent evaporation was uniform, and even though 
mannans were not dissolved, the obtained films were more evenly formed, composed of two different 
polymeric layers with apparent polymer segregation, but uniform layers nonetheless (figure 3.6 B).
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Figure 3.6. Methods for PHA/mannans films preparation.  
(A) PHA dissolved in chloroform and mannans dissolved in water; (B) mannans suspended in chloroform solution 
containing dissolved PHA. 
Using the second method (only chloroform), different polymeric ratios (presented as PHB/mannans 
ratios) were tested, namely 25/75 % (w/w), 50/50 % (w/w) and 75/25 % (w/w). Both 25/75 % (w/w) and 
50/50 % (w/w) ratios were discarded (figure 3.7 A and B, respectively), due to the incapacity to 
remove the films as a whole, caused by the rigid nature of the mannans layer. Using a 75/25 % (w/w) 
ratio (figure 3.7 C), the mannans layer was thinner and more flexible, and the amount of PHA located 
in the base layer was thick enough to endure the brittleness of the top layer (figure 3.7). 
 
Figure 3.7. Different polymeric ratios for film formation.  
(A) 25 % PHB, 75 % mannans; (B) 50 % PHB, 50 % mannans; (C) 75 % PHB, 25 % mannans. 
 
Different PHAs were then used for film formation, either alone (100 % PHA) or in conjunction with 
mannans following the 75/25 % (w/w) ratio tested above. In total, 12 different PHA films were 
obtained, six pure and six mixture, namely 100PHB (100 % PHB), 75PHB (75/25 % (w/w) 
PHB/mannans), 100PHBHV17 (100 % PHBHV17), 75PHBHV17 (75/25 % (w/w) PHBHV17/mannans), 
100PHBHV18 (100 % PHBHV18), 75PHBHV18 (75/25 % (w/w) PHBHV18/mannans), 100PHBHV27 
(100 % PHBHV27), 75PHBHV27 (75/25 % (w/w) PHBHV27/mannans), 100PHBHV38 (100 % 
PHBHV38), 75PHBHV38 (75/25 % (w/w) PHBHV38/mannans), 100PHBHV56 (100 % PHBHV56) and 
75PHBHV56 (75/25 % (w/w) PHBHV56/mannans), as shown in table 3.8. Pure PHA films (except 
100PHBHV56) and 75PHB are presented in figure 3.8. 
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Figure 3.8. Some PHA films prepared for biological assays.  
(A) 100PHB; (B) 75PHB; (C) 100PHBHV17; (D) 100PHBHV18; (E) 100PHBHV27; (F) 100PHBHV38. 
 
Table 3.8. PHA films prepared for biological assays.  
Film PHA Used PHA % (w/w) 
Mannans % 
(w/w) 
Malleability Translucency 
100PHB PHB 100 0 + + 
75PHB PHB 75 25 + - 
100PHBHV17 PHBHV17 100 0 + + 
75PHBHV17 PHBHV17 75 25 + - 
100PHBHV18 PHBHV18 100 0 - - 
75PHBHV18 PHBHV18 75 25 - - 
100PHBHV27 PHBHV27 100 0 ++ + 
75PHBHV27 PHBHV27 75 25 + - 
100PHBHV38 PHBHV38 100 0 ++ + 
75PHBHV38 PHBHV38 75 25 + - 
100PHBHV56 PHBHV56 100 0 ++ + 
75PHBHV56 PHBHV56 75 25 + - 
Results are presented as (-, absence; +, presence; ++, high presence). 
All plain PHA films prepared were perfectly uniform and presented considerable malleability and 
translucency (with the exception of 100PHBHV18, which presented some rigidity and opacity, 
presumably due to the extraction process in which bleach was used) (figures 3.8 A, C, D, E and F). 
PHAs extracted with hypochlorite have been reported to have significant drawbacks in terms of weight 
and polydispersity when compared to PHAs extracted with chloroform, as hypochlorite interacts with 
the polymer, degrading it. The resulting polymer has a lower molecular weight (reported as 50 to 70 % 
loss of molecular weight), but also a higher polydispersity [24, 25]. Moreover, bleach has been 
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previously used to whiten PHAs [53], which could account for its increased opaqueness. The HV 
content also proved impactful on film malleability (ductility), as films with higher HV contents were 
considerably more malleable, as expected [54]. Regarding mixture films, the bottom PHA layer 
presented similar malleability to their pure counterparts for lower HV content films. Higher HV content 
films were less malleable than their pure counterparts, but similar to lower HV content films, most 
likely due to the top mannans layer. Translucency, however, was absent from mixture films due to the 
uniformly distributed top layer of mannans over the PHA layer (figure 3.8 B). All PHA films prepared 
were sterilized in autoclave (121 ⁰C, 30 min), transferred to sealed petri dishes and laid aside for 
biological assays. 
 
 
Cytotoxicity assays were performed for both original mannans and its deproteinized version, using 
HCT116, A2780 and normal fibroblasts. Results are displayed in figure 3.9. 
 
Figure 3.9. Mannans influence in cell viability.  
(A) Effect of original mannans (MnOri); (B) Effect of deproteinized mannans (MnProt). Blue bars represent cell 
line A2780, orange bars represent cell line HCT116, grey bars represent normal skin fibroblasts cell line. Error 
bars represent the standard error of the mean of three independent assays. 
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Both mannans versions were tested, using the three cell lines mentioned, up to a maximum 
concentration of 500 µg mL-1. For all concentrations of both polymers studied, no effect on cell viability 
was observed (cell viability remains near 100 %). This effect is observed for all cell lines tested (Figure 
3.9). Furthermore, both polymers present very similar patterns, which most likely means that the 
proteins present in the original polymer have no influence on cell viability (Figure 3.9). Given this 
result, mannans were proven to have no cytotoxic effect on any of the cell lines tested, rendering them 
suitable to be used in further biological studies. Deproteinized mannans were discarded from further 
tests, as the proteins present in the original polymer also have no cytotoxic effect. 
The original version of the polymer was also tested in skin fibroblasts, up to a concentration of 2000 
µg mL-1, aiming at a possible application of this polymer in wound dressing. Results are displayed in 
figure 3.10. 
 
 
Figure 3.10. Mannans influence in normal skin fibroblast cell viability (high concentrations).  
Grey bars represent normal skin fibroblasts cell line. Error bars represent the standard error of the mean of three 
independent assays. 
 
In this assay, cell viability seems to slightly increase with the concentration of polymer in the medium 
(up to 1500 µg mL-1) to as much as 140 % of its control value, opening the possibility that skin 
fibroblasts could use the polymer as a substrate, potentially raising the mitochondrial activity level 
(Figure 3.10). This effect is true up to 1900 µg mL-1, from which it starts to diminish, presumably due to 
a high concentration of polymer which may impair good homogenizing of the medium, preventing cell 
access to certain nutrients. Nevertheless, cell viability remains near 100 % (Figure 3.10). 
Wound regeneration is a complex process, coordinating the activity of different cell lines as well as 
growth factors and matrix signals. Among the major players in this process are dermal fibroblasts, 
which migrate to the site of the skin lesion, and are responsible for the production of a collagen-rich 
matrix which supports epidermal cells and allows them to proliferate and reform the skin [55]. 
Mannans are hereby proven to increase skin fibroblast cell viability, which can be translated in one of 
two occurrences: an increase in the mitochondrial activity of the cell, or an increase in the total number 
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of cells. Further tests, such as dsDNA quantification or protein quantification, could be performed to 
determine which of these is true [56]. 
At any rate, if skin fibroblasts are able to use the polymer as a substrate, by means of its degradation 
(degrading mannans to their respective monomers, mainly mannose), this polymer could end up being 
used in wound healing in more than just a fibroblast stimulant. Scarring is also an important factor in 
wound healing, which is highly mediated by TGF-β1 (one of the growth factors which induce 
fibroblasts to produce the collagen-rich matrix). In adults, TGF-β1 remains at the wound site for 
prolonged periods of time, even after the collagen matrix is completed, contributing to the formation of 
scarred tissue. Although specific antibodies or TGF-β3 have been used before to inhibit TGF-β1, 
mannose-6-phosphate (M-6-P) has also been described to inhibit TGF-β1, by means of the (M-6-P)-
IGF II receptor [55]. As such, mannans degraded into mannose by the fibroblasts could prove valuable 
in preventing scarring, more so if the polymer has a high degree of phosphorylation. 
 
 
 
Cell adherence assays were conducted in skin fibroblasts using the mannans films (MnOri30, MnOri-
90, MnOriFeFilm, MnOriFeNaOHFilm, MnOriFeBeads30 and MnOriFeBeads-90) in an attempt to test 
their capability to be used as an adherence matrix for wound dressing applications (figure 3.11).  
Immediately after the addition of the cell suspension, MnOri-90 (figure 3.11 B) and MnOriFeBeads-90 
(figure 3.11 D) films obtained by freeze drying disintegrated and solubilized, rendering this drying 
method impractical for this application. This effect was most likely caused by the large contact surface 
area between the polymer and the cell culture medium, causing the matrix to collapse and dissolve. 
MnOri30 completely disintegrated and solubilized after the 24 h period given for cell adhesion in 
biological assays (figure 3.11 A). Mannans are highly soluble in water and, despite the tight structure 
of the film, the polymer quickly solubilized especially when submitted to a higher temperature (37 °C) 
than room temperature. 
With respect to MnOriFeBeads30 (figure 3.11 C) and MnOriFeFilm (figure 3.11 E) films, a complete 
loss of all their structure was observed after the 24 h incubation period, however they did not 
completely solubilize. Particles of their original structure were still visible attached to the bottom of the 
cell culture plate, but the most part was suspended in the culture medium. This leads to the conclusion 
that the mixture of polymer and iron salt was highly imperfect, as the most part of the two films was 
still soluble, presenting just a few insoluble particles. Regarding MnOriFeFilm (figure 3.11 E), only a 
coat of iron could be achieved on top of the original film prepared, which could have been disrupted 
and separated from the inside uncoated part, probably due the temperature used. Another possible 
explanation could be the lack of NaOH in the film formation process, making the iron coat simply less 
soluble, yet not insoluble. MnOriFeBeads30 (figure 3.11 C) were prepared using a mixture of the 
polymer and the iron salt dissolved in deionized water, which does not support the hypothesis of the 
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poor mixture of the two components. The fact that the corresponding beads are only formed after they 
are dropped in the NaOH solution could present an explanation, as only the outer layer becomes truly 
insoluble by the action of the alkaline solution, and the integrity of the shell of the beads could be 
compromised by the drying process, thus rendering them useless by exposing part of their interior 
soluble fraction. This later explanation, however, does not support what happened with the last film, 
MnOriFeNaOHFilm (figure 3.11 F). This film suffered an identical transformation process to the beads 
(iron salt followed by NaOH) thus forming the iron coat made insoluble by the action of the alkaline 
solution but did not disintegrate after the 24 h period of cell incubation as the previous two 
experiments, which leads to the conclusion that the coat was not compromised by the drying process 
and thus did not expose any interior soluble components. As to the difference between the beads film 
(MnOriFeBeads30) and the MnOriFeNaOHFilm film, the latter has a tighter interior, making it more 
resistant to fractures during the drying process which could account for the different results. 
 
 
Figure 3.11. Mannans films used in cell adherence assays.  
(A) MnOri30 after the 24 h incubation period; (B) MnOri-90 immediately after adding the cell suspension; (C) 
MnOriFeBeads30 after the 24 h incubation period; (D) MnOriFeBeads-90 immediately after adding the cell 
suspension; (E) MnOriFeFilm after the 24 h incubation period; (F) MnOriFeNaOHFilm after the 24 h incubation 
period. All cell culture plates are tilted for better visualization of either dissolution or suspension of the films in the 
culture medium. 
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Still, after microscopic observation of MnOriFeNaOHFilm after the cell adherence period (figure 3.12), 
no cells were visible on top of the film, and as such this line of research was abandoned. 
 
Figure 3.12. Microscopic observation of MnOriFeNaOHFilm after the cell adherence period (24 h). 
The film corresponds to the darker section, whereas the lighter section corresponds to the bottom of the cell 
culture plate. Normal skin fibroblasts are visible adherent to the cell culture plate, displaying an elongated 
structure. No visible cells are found in the film section. The figure was obtained with total ampliation of 40x (10x 
ocular and 4x objective), and the scale bar represents 250 µm. 
 
 
All twelve PHA films were used in cell adherence studies. PHB, PHBHV17 and 100PHBHV18 were 
tested using skin fibroblasts and MCF7-GFP, and the other PHA films were tested only in MCF7-GFP 
(MCF7 cells modified to produce GFP, a green fluorescent protein). Skin fibroblasts were initially used 
as a target for these polymers’ application, namely in wound dressing. However, microscopic 
observation of adherent cells was not always possible due to the film opacity, and so MCF7-GFP were 
used instead, using fluorescence as differentiation from the film structure. The use of fluorescent 
protein modified cells was also subject of difficult observation, as PHA polymers were discovered to 
have fluorescence of their own, although not as much as modified MCF7 cells. Microscopical 
observation of adherent cells is presented from figure 3.13 to figure 3.24. 
Overall, PHA films proved capable of supporting cell adherence. In pure PHA films (100 % PHA) it 
was possible to observe multiple cells, both when using fibroblasts (observed in brightfield) or MCF7-
GFP (observed using fluorescence filters) (figures 3.13, 3.15, 3.19, 3.21 and 3.23). Cells were able to 
adhere to 100PHB (figure 3.13 A, C, D and E), 100PHBHV17 (figure 3.15 A, C, D and E), 
100PHBHV27 (figure 3.19 B, C and D), 100PHBHV38 (figure 3.21 B, C and D) and 100PHBHV56 
(figure 3.23 B, C and D). However, when considering 100PHBHV18 films (figure 3.17 A, C, D and E), 
an inefficient adherence was observed, as no cells were visible on its surface. This might be due to i) 
the nature of its extraction (using bleach as a membrane disrupting agent) rendering the film opaquer 
and thus hindering visualization, or ii) an incomplete purification of the same, in which remnants of 
bleach could act against the cells. 
Regarding the mannans/PHA films blends, visualization of adherent cells was hindered by the upper 
 37 
 
layer of mannans, which were opaquer than the lower layer of PHA. Nevertheless, cells could still be 
observed using fluorescence filters, though in a much lower extent, in 75PHB (figure 3.14 A, C, D and 
E) and 75PHBHV38 mixture films (figure 3.22 B, C and D). While the diminishing of visually adherent 
cells was to be expected by the opacity factor in play, there was no visual observation of adherent 
cells in either of the other blend films (figures 3.16, 3.18, 3.20 and 3.24).  
Films made of homopolymer PHB and co-polymeric PHB blends, such as P(3-HB-co-4-HB), have 
been investigated for their in vitro capacity to support cell adherence, and proved suitable to be used 
as porous matrices for applications such as wound dressing. It was discovered that films made of 
these polymers were good matrices for cell growth, with multiple sized pores interconnected in the film 
structure suitable for nutrients diffusion and cellular waste disposal. Moreover, cell adhesion assays 
displayed several fibroblasts attached to the PHB matrix surface, which are in agreement with the 
results obtained in this work [40, 41]. 
In the cited literature, however, these results pale in comparison to those obtained for blended PHAs, 
namely PHB or P(3-HB-co-4-HB) with polysaccharides. Using bacterial cellulose to produce polymeric 
blends with the aforementioned polyesters, Zhijiang and co-workers discovered that the new 
polyester-polysaccharide blends were even more suitable for biological applications [40, 41]. Films 
made from these new blends had a better internal pore structure, as well as a polysaccharide matrix to 
aid protein anchoring to the film, allowing cells to adhere with more ease. More fibroblast cells were 
found adherent to these structures, as well as a change in their morphology which suggested they 
were proliferating. As such, these blend matrices were found to be much better suited for biological 
applications such as wound dressing [40, 41]. These results are hard to compare with the ones 
obtained in this work. The blend films in the cited literature were prepared in a different way (using a 
solvent adequate for dissolving both polymers, TFA) and therefore there was no double layer with 
polymer segregation, and also another polysaccharide was used, which has a different composition. 
These matrices were more homogenous and resulted in a better cell adherence, which was not 
observed in this study. Despite that fact, cells were found to adhere to the some of the blended 
polymeric matrices in this study. Considering the mentioned difficulty in the observation of adherent 
cells and the results published for other polyester-polysaccharide blends, it is reasonable to assume 
that, if better polyester-polysaccharide blends are achieved, their resulting films could provide a better 
adherence surface, and therefore used in tissue regeneration applications. 
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Figure 3.13. Cell growth in 100PHB films.  
(A) 100PHB with skin fibroblasts (Brightfield); (B) 100PHB with no cells (Blue excitation); (C) 100PHB with MCF7-
GFP (Brightfield); (D) 100PHB with MCF7-GFP (Blue excitation); (E) Superimposed images of 100PHB with 
MCF7-GFP in brightfield and blue excitation (figures C and D). In figures (A) and (C) cells are round projections 
on the film surface, and in figures (D) and (E) cells are green spots on the film surface. All figures were obtained 
with total ampliation of 200x (10x ocular and 20x objective), and the scale bar represents 50 µm. 
 
 
Figure 3.14. Cell growth in 75PHB films.  
(A) 75PHB with skin fibroblasts (Brightfield); (B) 75PHB with no cells (Blue excitation); (C) 75PHB with MCF7-
GFP (Brightfield); (D) 75PHB with MCF7-GFP (Blue excitation); (E) Superimposed images of 75PHB with MCF7-
GFP in brightfield and blue excitation (figures C and D). In figures (A) and (C) cells are round projections on the 
film surface, and in figures (D) and (E) cells are green spots on the film surface. All figures were obtained with 
total ampliation of 200x (10x ocular and 20x objective), and the scale bar represents 50 µm. 
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Figure 3.15. Cell growth in 100PHBHV17 films.  
(A) 100PHBHV17 with skin fibroblasts (Brightfield); (B) 100PHBHV17 with no cells (Blue excitation); (C) 
100PHBHV17 with MCF7-GFP (Brightfield); (D) 100PHBHV17 with MCF7-GFP (Blue excitation); (E) 
Superimposed images of 100PHBHV17 with MCF7-GFP in brightfield and blue excitation (figures C and D). In 
figures (A) and (C) cells are round projections on the film surface, and in figures (D) and (E) cells are green spots 
on the film surface. Figures (A) and (B) were obtained with total ampliation of 200x (10x ocular and 20x objective), 
and the scale bar represents 50 µm. Figures (C), (D) and (E) were obtained with total ampliation of 400x (10x 
ocular and 40x objective), and the scale bar represents 25 µm. 
 
 
Figure 3.16. Cell growth in 75PHBHV17 films.  
(A) 75PHBHV17 with skin fibroblasts (Brightfield); (B) 75PHBHV17 with no cells (Blue excitation); (C) 
75PHBHV17 with MCF7-GFP (Brightfield); (D) 75PHBHV17 with MCF7-GFP (Blue excitation); (E) Superimposed 
images of 75PHBHV17 with MCF7-GFP in brightfield and blue excitation (figures C and D). In figures (A) and (C) 
cells are round projections on the film surface, and in figures (D) and (E) cells are green spots on the film surface. 
All figures were obtained with total ampliation of 200x (10x ocular and 20x objective), and the scale bar 
represents 50 µm. 
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Figure 3.17. Cell growth in 100PHBHV18 films.  
(A) 100PHBHV18 with skin fibroblasts (Brightfield); (B) 100PHBHV18 with no cells (Blue excitation); (C) 
100PHBHV18 with MCF7-GFP (Brightfield); (D) 100PHBHV18 with MCF7-GFP (Blue excitation); (E) 
Superimposed images of 100PHBHV18 with MCF7-GFP in brightfield and blue excitation (figures C and D). In 
figures (A) and (C) cells are round projections on the film surface, and in figures (D) and (E) cells are green spots 
on the film surface. All figures were obtained with total ampliation of 200x (10x ocular and 20x objective), and the 
scale bar represents 50 µm. 
 
 
Figure 3.18. Cell growth in 75PHBHV18 films.  
(A) 75PHBHV18 with no cells (Blue excitation); (B) 75PHBHV18 with MCF7-GFP (Brightfield); (C) 75PHBHV18 
with MCF7-GFP (Blue excitation); (D) Superimposed images of 75PHBHV18 with MCF7-GFP in brightfield and 
blue excitation (figures B and C). In figure (B) cells are round projections on the film surface, and in figures (C) 
and (D) cells are green spots on the film surface. All figures were obtained with total ampliation of 200x (10x 
ocular and 20x objective), and the scale bar represents 50 µm. 
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Figure 3.19. Cell growth in 100PHBHV27 films.  
(A) 100PHBHV27 with no cells (Blue excitation); (B) 100PHBHV27 with MCF7-GFP (Brightfield); (C) 
100PHBHV27 with MCF7-GFP (Blue excitation); (D) Superimposed images of 100PHBHV27 with MCF7-GFP in 
brightfield and blue excitation (figures B and C). In figure (B) cells are round projections on the film surface and in 
figures (C) and (D) cells are green spots on the film surface. All figures were obtained with total ampliation of 200x 
(10x ocular and 20x objective), and the scale bar represents 50 µm. 
 
 
Figure 3.20. Cell growth in 75PHBHV27 films.  
(A) 75PHBHV27 with no cells (Blue excitation); (B) 75PHBHV27 with MCF7-GFP (Brightfield); (C) 75PHBHV27 
with MCF7-GFP (Blue excitation); (D) Superimposed images of 75PHBHV27 with MCF7-GFP in brightfield and 
blue excitation (figures B and C). In figure (B) cells are round projections on the film surface and in figures (C) and 
(D) cells are green spots on the film surface. All figures were obtained with total ampliation of 200x (10x ocular 
and 20x objective), and the scale bar represents 50 µm. 
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Figure 3.21. Cell growth in 100PHBHV38 films.  
(A) 100PHBHV38 with no cells (Blue excitation); (B) 100PHBHV38 with MCF7-GFP (Brightfield); (C) 
100PHBHV38 with MCF7-GFP (Blue excitation); (D) Superimposed images of 100PHBHV38 with MCF7-GFP in 
brightfield and blue excitation (figures B and C). In figure (B) cells are round projections on the film surface and in 
figures (C) and (D) cells are green spots on the film surface. All figures were obtained with total ampliation of 200x 
(10x ocular and 20x objective), and the scale bar represents 50 µm. 
 
 
Figure 3.22. Cell growth in 75PHBHV38 films.  
(A) 75PHBHV38 with no cells (Blue excitation); (B) 75PHBHV38 with MCF7-GFP (Brightfield); (C) 75PHBHV38 
with MCF7-GFP (Blue excitation); (D) Superimposed images of 75PHBHV38 with MCF7-GFP in brightfield and 
blue excitation (figures B and C). In figure (B) cells are round projections on the film surface and in figures (C) and 
(D) cells are green spots on the film surface. All figures were obtained with total ampliation of 200x (10x ocular 
and 20x objective), and the scale bar represents 50 µm. 
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Figure 3.23. Cell growth in 100PHBHV56 films.  
(A) 100PHBHV56 with no cells (Blue excitation); (B) 100PHBHV56 with MCF7-GFP (Brightfield); (C) 
100PHBHV56 with MCF7-GFP (Blue excitation); (D) 100PHBHV56 with MCF7-GFP (Brightfield), with a green 
rectangle delimiting to the area where figure (C) would superimpose. In figures (B) and (D) cells are round 
projections on the film surface and in figure (C) cells are green spots on the film surface. Figures (A), (B) and (D) 
were obtained with total ampliation of 200x (10x ocular and 20x objective), and the scale bar represents 50 µm. 
Figure (C) was obtained with total ampliation of 400x (10x ocular and 40x objective), and the scale bar represents 
25 µm. 
 
 
Figure 3.24. Cell growth in 75PHBHV56 films.  
(A) 75PHBHV56 with no cells (Blue excitation); (B) 75PHBHV56 with MCF7-GFP (Brightfield); (C) 75PHBHV56 
with MCF7-GFP (Blue excitation); (D) Superimposed images of 75PHBHV56 with MCF7-GFP in brightfield and 
blue excitation (figures B and C). In figure (B) cells are round projections on the film surface and in figures (C) and 
(D) cells are green spots on the film surface. All figures were obtained with total ampliation of 200x (10x ocular 
and 20x objective), and the scale bar represents 50 µm. 
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Cell viability was also tested for adherent cells on some PHA films (using MCF7-GFP), based on the 
previous results for cell adherence and polymer availability. Regarding the results for cell adherence, 
only 100 % PHA films were selected. Also, of the six different polymers previously tested, PHB and 
PHBHV56 were unavailable. As such, only four different films were selected, namely 100PHBHV17, 
100PHBHV18, 100PHBHV27 and 100PHBHV38 (figure 3.25). 
 
 
Figure 3.25. Cell viability of adherent MCF7-GFP cells in different PHA films.  
Blue bars represent cell line MCF7-GFP. Error bars represent the standard error of the mean of two independent 
assays. 
 
When observing figure 3.25, no correlation between film composition and cell viability was observed. 
100PHBHV17 and 100PHBHV38 films show no cytotoxicity (> 100 % cell viability), while 
100PHBHV27 shows a slightly decrease of cell viability (figure 3.25). Regarding cells tested on 
100PHBHV18 films, a complete loss of cell viability was observed (figure 3.25). This result is in 
agreement with the possibility that this polymer’s purification might have been unsuccessful, leaving 
residual bleach in the polymer which could hinder cell growth. Reported studies performed using PHB 
and PHBHV films in vitro are sometimes contradictory, due to the experimental conditions that greatly 
affect the results. It has been reported that an increase in HV content may be responsible for a slight 
decrease in cell viability in vitro. However, different studies appointed causes for this phenomena 
related to the purity of the polymers used (in terms of cell debris, such as saturated fatty acids) rather 
than the HV content, and reported that highly purified polyesters with varying HV contents are equally 
biocompatible [39], which could explain the differences observed in figure 3.25, meaning that 
100PHBHV27 could have simply been prepared from a less purified polymer. 
Overall, the matrices prepared from PHAs extracted and purified with chloroform were biocompatible 
and proved capable of supporting cell adherence in vitro, especially when made solely of polyester. 
The hypochlorite extraction method proved inefficient in yielding PHAs for biological applications, as a 
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similar purification method employed for the chloroform extracted PHAs was used, which in this case 
was apparently not effective. Also, as previously discussed, a different method for obtaining polyester-
polysaccharide blends could yield better results for cell adherence, as described in the cited literature. 
Nevertheless, the results obtained are inconclusive in that regard derived from the observation 
constraints imposed by the opacity of the films. 
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In this thesis, two different polymers were used to prepare structures for biomedical applications, 
namely polysaccharide gel particles for drug delivery and polymeric films for both drug delivery and 
wound dressing applications. 
Mannans were produced by K. pastoris using glycerol as carbon source and polyhydroxyalkanoates 
(PHAs) were produced by mixed cultures using fermented fruit pulp waste. 
Two transformation procedures were tested in mannans, a deproteinization and a phosphorylation 
procedure. The deproteinization was partially successful, removing 69.49 ± 0.44 % of the total protein 
of the mannans sample, but reduced the available polymer to 41.19 ± 1.73 %. The phosphorylation 
procedure was unsuccessful. Only 29.72 % of the sample was able to be recovered, with a total loss 
in phosphate groups of 60.45 ± 1.23 %. 
Mannans and their deproteinized version were tested in normal fibroblasts, A2780 and HCT116 cell 
lines, and were found to have no cytotoxicity for either of the cell lines tested, proving mannans could 
be used in future biological assays and rendering the deproteinization method an unnecessary step for 
mannans to be used in biological applications. 
This polysaccharide was then used to prepare biopolymeric matrices for medical applications. 
Mannans were firstly investigated for their capability to form gels. Different methods were used, and 
the effect of temperature, pH and salt concentration was tested. Mannans were found to gel under low 
temperature (4 ⁰C) and alkaline pH, and under preferential interaction with higher concentrations of 
iron and copper salts. Gel particles were developed considering the gelling conditions described 
above, using six different methods. The effect of cation valence was also tested. The method using a 
tri-valent cation (iron) followed by NaOH yielded the best gel particles regarding their stability. 
Mannans were also used to prepare films, and the effect of plasticizers (glycerol and polyethylene 
glycol) was tested. In the concentrations used, the plasticizers had no positive effect, and were 
consequently discarded. Mannans films were also tested for their drying process, and films dried at 30 
⁰C or freeze dried were obtained. Mannans films were also used to develop a new type of insoluble 
film following the gelation procedures tested with iron salts, and two methods were accomplished, 
using a previously prepared film dipped in an iron salt solution, and then either dipped in a NaOH 
solution or not. Also, gel beads obtained in method 4 for gelation procedures were used to prepare 
films. In total, six different films (mannans film dried at 30 ⁰C, mannans film freeze dried, mannans film 
dipped in iron solution, mannans film dipped in iron solution and NaOH solution, mannans gel beads 
dried at 30 ⁰C and mannans gel beads freeze dried) were tested in fibroblasts. Of those six, only the 
mannans film dipped in iron solution and NaOH solution resisted the cell growth conditions, but no 
cells were visible attached to it. 
PHAs with different compositions (pure PHB and co-polymeric PHBHV with different HV contents) 
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were used to produce films, alone and blended with mannans. The process of blending PHA and 
mannans was investigated, regarding the solvent used and the proportions of both polymers. 
Chloroform was the elected solvent for the PHA-mannans blending process, and optimal PHA-
mannans ratio for that blending process was achieved at 75 % PHA and 25 % mannans. Blended 
films had a two-layer structure with apparent segregation of polymers, composed of a PHA bottom 
layer and a mannans top layer. 
Twelve different films (six pure PHA and six blends) were produced and tested in normal fibroblasts or 
MCF7-GFP cell line. Overall, pure PHA films were found adequate for cell adherence, with the 
exception of the film made of PHBHV with an HV content of 18 %, most likely due to the inefficient 
extraction process it was submitted to. Blended PHA-mannans films were found mostly uncapable of 
supporting cell adhesion, with visible adherent cells in only two blend films (75PHB and 75PHBHV38) 
and to a much lower extent than their pure counterparts. This could be due to the blending process, 
since blended PHA-polysaccharide films were found adept for cell adhesion in the literature. Pure PHA 
films were also tested for their cytotoxicity. The results confirmed the observations made in the cell 
adherence assays, as most PHA films showed no cytotoxicity. The film made of PHBHV with 18 % HV 
was also shown to be cytotoxic for the cells, supporting the claims of a hypochlorite contamination due 
to an inefficient extraction process. 
As for future work, much is left undone. First of all, as discussed, phosphomannans have been 
described as having antitumor activity. More than just a drug delivery system, this polymer could act 
as a cancer pharmaceutical by itself, and therefore different methods to yield such a polymer should 
be tested. 
On a second note, in this thesis mannans gel particles have been successfully obtained, but the 
method could still be optimized, as their stability could be improved. These gel beads were not verified 
for their cytotoxic activity, metal release profiles, or encapsulation of pharmaceuticals, which is yet to 
be tested. 
Lastly, most of the pure PHA films in use have shown great potential for cell adhesion assays and 
further studies should be carried out, including an extensive characterization of these matrices, as well 
as their capacity to incorporate pharmaceuticals for drug delivery. Their blend counterparts, however, 
left a lot to be desired. This was an unexpected result, as the supporting literature clearly states the 
potential of such films. In this regard, the method used for blending should be revisited. The most 
likely route would be a method involving a solvent which could dissolve both polymers, such as TFA, 
to achieve proper homogenization of the matrix. 
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